摘要
肺动脉高压(PH)是以肺动脉系统循环阻力进行性增加为特征的一组疾病,其病理过程涉及肺血管的收缩和重构、肺血管平滑肌和内皮细胞的异常增生以及原位血栓形成等。这些病理变化导致肺动脉压力升高,加重右心室负荷,最终可能引发右心功能衰竭而死亡。近些年来随着诊疗水平的提升,以及人们就诊意愿的提高,肺动脉高压被越来越多的诊断。但对于其病因、治疗、管理及合并症等方面仍是难点,其次当患者确诊PH时已错过最佳治疗时期。因此提高对肺动脉高压的认识、正确的早期筛查及早期治疗十分重要。本文就肺动脉高压病因、治疗管理及合并症等研究的进展进行综述。
Pulmonary hypertension (PH) is a group of diseases characterized by progressive increase in circulatory resistance of the pulmonary artery system. The pathologic process involves contraction and remodeling of pulmonary blood vessels, abnormal proliferation of pulmonary smooth muscle and endothelial cells, and in-situ thrombosis. These pathological changes lead to increased pulmonary artery pressure and increased right ventricular load, which may eventually lead to right heart failure and death. In recent years, with the improvement of diagnosis and treatment level and the improvement of people’s willingness to seek medical treatment, pulmonary hypertension has been diagnosed more and more. However, the etiology, treatment, management and comorbidities are still difficult. Secondly, when patients are diagnosed with PH, the optimal treatment period has been missed. Therefore, it is very important to improve the understanding of pulmonary hypertension, correct early screening and early treatment. This article reviews the progress of the etiology, treatment, management and complications of pulmonary hypertension.
出处
《临床医学进展》
2024年第6期711-716,共6页
Advances in Clinical Medicine
